Canada - English - Health Canada

laboratoire riva inc. - donepezil hydrochloride (donepezil hydrochloride monohydrate) - tablet - 10mg - donepezil hydrochloride (donepezil hydrochloride monohydrate) 10mg - parasympathomemetic (cholinergic) agents

Canada - English - Health Canada

pro doc limitee - donepezil hydrochloride (donepezil hydrochloride monohydrate) - tablet - 5mg - donepezil hydrochloride (donepezil hydrochloride monohydrate) 5mg - parasympathomemetic (cholinergic) agents

Canada - English - Health Canada

pro doc limitee - donepezil hydrochloride (donepezil hydrochloride monohydrate) - tablet - 10mg - donepezil hydrochloride (donepezil hydrochloride monohydrate) 10mg - parasympathomemetic (cholinergic) agents

Canada - English - Health Canada

sanis health inc - donepezil hydrochloride (donepezil hydrochloride monohydrate) - tablet - 5mg - donepezil hydrochloride (donepezil hydrochloride monohydrate) 5mg - parasympathomemetic (cholinergic) agents

Canada - English - Health Canada

sanis health inc - donepezil hydrochloride (donepezil hydrochloride monohydrate) - tablet - 10mg - donepezil hydrochloride (donepezil hydrochloride monohydrate) 10mg - parasympathomemetic (cholinergic) agents

Canada - English - Health Canada

dominion pharmacal - donepezil hydrochloride (donepezil hydrochloride monohydrate) - tablet - 5mg - donepezil hydrochloride (donepezil hydrochloride monohydrate) 5mg - parasympathomemetic (cholinergic) agents

Canada - English - Health Canada

dominion pharmacal - donepezil hydrochloride (donepezil hydrochloride monohydrate) - tablet - 10mg - donepezil hydrochloride (donepezil hydrochloride monohydrate) 10mg - parasympathomemetic (cholinergic) agents

United States - English - NLM (National Library of Medicine)

rising pharmaceuticals, inc. - benazepril hydrochloride (unii: n1sn99t69t) (benazeprilat - unii:jrm708l703), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - benazepril hydrochloride 10 mg - benazepril hcl and hydrochlorothiazide is indicated for the treatment of hypertension. this fixed combination drug is not indicated for the initial therapy of hypertension (see dosage and administration). benazepril hcl and hydrochlorothiazide is contraindicated in patients who are anuric. benazepril hcl and hydrochlorothiazide is also contraindicated in patients who are hypersensitive to benazepril, to any other ace inhibitor, to hydrochlorothiazide, or to other sulfonamide-derived drugs. hypersensitivity reactions are more likely to occur in patients with a history of allergy or bronchial asthma. benazepril hcl and hydrochlorothiazide is also contraindicated in patients with a history of angioedema with or without previous ace inhibitor treatment. benazepril hcl and hydrochlorothiazide is contraindicated in combination with a neprilysin (e.g., sacubitril). do not administer benazepril hcl and hydrochlorothiazide within 36 hours of switching to or from sacubitril/valsartan a neprilysin inhibitor (see warning

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - oxybutynin hydrochloride - tablet - 2.5 milligram(s) - drugs for urinary frequency and incontinence; oxybutynin

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - oxybutynin hydrochloride - tablet - 5 milligram(s) - drugs for urinary frequency and incontinence; oxybutynin